Comparer des méthodes

	Échelle de Qualité de Vie pour la Polyarthrite Rhumatoïde	EORTC QLQ-C30
Domaine	Résultats de santé	Résultats de santé
Famille	Process / pipeline	Process / pipeline
Année d'origine	1997	1993
Auteur d'origine	Stephen P. McKenna et al.	Nico Aaronson et al.
Type	Self-report quality of life questionnaire	Self-report quality of life questionnaire
Source fondatrice	de Jong, Z., van der Heijde, D. M., McKenna, S. P., & Whalley, D. (2000). The Rheumatoid Arthritis Quality of Life Scale (RAQoL): Final Dutch version allows three methods of data handling. Arthritis & Rheumatism, 13(6), 408-413.	Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376.
Alias	RA-QoL, Rheumatoid Arthritis QoL, RAQoL	QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale
Apparentées	4	5
Résumé	The RA-QoL is a disease-specific quality of life measure for rheumatoid arthritis (RA). Developed by Stephen McKenna and colleagues in 1997, this 30-item questionnaire quantifies how RA affects daily activities, emotional well-being, functional independence, and social engagement. It is a standard outcome measure in RA research and clinical trials, capturing dimensions beyond joint inflammation and functional disability.	The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care.